Raghuveer Dendi is a Cardiology physician affiliated with University of Kansas. OpenAlex indexes 93 publications with 1,475 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3901 Rainbow Blvd
Suite G600
Kansas City, KS 661608500
Telephone
913-588-9600Registry record last updated 29 Sept 2017.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202523 payments
- Medtronic, Inc.Program year202514 payments
- Boston Scientific CorporationProgram year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.9%Beta blocker24.5%Metoprolol Succinate39%Metoprolol Tartrate19%Carvedilol19%Sotalol16%Nebivolol Hcl4%Nadolol2%Atenolol2%Part D<11 patientsAntiarrhythmic16%Dofetilide34%Flecainide Acetate31%Amiodarone Hcl19%Multaq13%Mexiletine Hcl3%Part D<11 patients+ 13 more classes in this area
Blood & clotting
24.1%Factor Xa inhibitor17.9%Eliquis75%Xarelto26%Part D≥100 patientsP2Y12 inhibitor2.7%Clopidogrel100%Part D≥45 patients+ 3 more classes in this area
Metabolism & gastrointestinal
3.6%Potassium supplement2%Potassium Chloride100%Part D≥23 patientsProton pump inhibitor1.1%Pantoprazole Sodium100%Part D≥28 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Recurrence of Atrial Fibrillation/Flutter Over Long‐Term Follow‐Up After Index Atrial Fibrillation Catheter Ablation
Journal of Cardiovascular Electrophysiology
2026 - Cardiac resynchronization therapy for pacing induced cardiomyopathy: Role of baseline right ventricular pacing burden
Pacing and Clinical Electrophysiology
2024 - RISK OF ACUTE DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM AFTER TRANSVENOUS LEAD EXTRACTION
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Simari, MD
University of Kansas
Tara Lin, MD
University of Kansas
Diane Cibrik, MD
University of Kansas
Martin Mainster, MD
University of Kansas
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”